MALISA OVERBEY: Open Payments
NPI 1437417565 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 18 payments from 9 companies in 2025. Trend: 2023 $520 · 2024 $878 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 1 | $192 |
| Medtronic, Inc. | 1 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $86 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Daiichi Sankyo Inc. | 2 | $53 |
| Actelion Pharmaceuticals US, Inc. | 2 | $48 |
| Amgen Inc. | 2 | $29 |
| Abbott Laboratories | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: Barostim Neo System, SYMPLICITY G3, Kerendia, LEQVIO, INJECTAFER, OPSUMIT, REPATHA, CARDIOMEMS.
Industry payments across TN — which companies pay providers there.
